PetVivo Holdings Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
PetVivo Holdings Inc provides update on Kush(TM) Study Results
PetVivo Holdings Inc:To provide an update on the Kush study results for treating animal osteoarthritis.PetVivo has licensed the Kush device from Gel-Del Technologies, Inc. and is planning a launch in Q4 of this year.PetVivo CEO John Lai says Kush device, demonstrating great safety data for over eight years in five species, including people, case-study reports to treat bad joints in horses, started 3 years ago, and dogs, started 6 months ago, have been very positive.
Latest Developments for PetVivo Holdings Inc
- Share this
- Digg this